Answers are grounded in this paper and cite their sources.
Supplementary figure reveals gut microbiota profiles in myeloma patients before CAR-T therapy, suggesting implications for response outcomes.
Supplementary Figure S2 illustrates the pre-CAR T-cell infusion gut microbiota taxonomic profiles in multiple myeloma patients, specifically detailing order and family-level compositions at apheresis and before lymphodepletion, along with comparisons of relative mean abundances between these time points.
No takes yet. Share an insight, caveat, or question.
Uribe‐Herranz et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: